Urso DS · DIN 02245894 · 500 mg · tablet
Limited Use, Reason for Use code 273, 386 required; Health Canada lists this DIN as Cancelled post market since 2023-06-26 — choose a marketed DIN from the same-category list.Discontinued June 26, 2023 · checked November 19, 2026
StatusLimited Use, Reason for Use code 273, 386 required; Health Canada lists this DIN as Cancelled post market since 2023-06-26 — choose a marketed DIN from the same-category list.
Write on scriptone applicable Reason for Use code, 273 or 386 (criteria below); Health Canada lists this DIN as Cancelled post market since 2023-06-26 — choose a marketed DIN from the same-category list.
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.
Ontario Limited Use criteria, code 273, 386
Reason for Use code 273
For the treatment of primary biliary cirrhosis.
Coverage limit:
LU Authorization Period: Indefinite
Reason for Use code 386
For the treatment of primary sclerosing cholangitis.
Coverage limit:
LU Authorization Period: Indefinite
1 brand, same coverage
Urso DS · DIN 02245894
Manufacturer: Axcan Pharma Inc.; listing date 2004-04-06
Health Canada: Cancelled post market since 2023-06-26 · brand URSO DS · ATC A05AA02 URSODEOXYCHOLIC ACID · form Tablet · route Oral · ingredients URSODIOL 500 MG · company Aptalis pharma canada ulc · schedule Prescription
Ministry pays: $0.7242 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02245894)
Source record
DIN 02245894: Urso DS
Raw flags: sec12=Y, sec3=Y
Item: 920000494; group id 977; item number 2313; lccId 00158; manufacturer id BFI
Source form: Tab; strength: 500mg
Recorded listing: Limited Use: paid only with a Reason for Use code and the criteria below
Source prices (unrounded): $3.1751; ministry $0.7242
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02245894
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=70011
Interchangeable products
AG-Ursodiol · DIN 02505371 · $0.7242
GLN-Ursodiol · DIN 02426919 · $0.7242
Jamp-Ursodiol · DIN 02472406 · $0.7242
NRA-Ursodiol · DIN 02544024 · $0.7242
PMS-Ursodiol C · DIN 02273500 · $0.7242
Ursodiol C · DIN 02515539 · $0.7242
Shortage status: not checked (no credentials)
Health Canada lists this DIN as Cancelled post market since June 26, 2023 — choose a marketed DIN from the same-category list.